Pulling SEC filings + quote and writing the call…

Privia Health Group, Inc.
Next earnings Aug 5, 2026 (before open) · consensus $0.07 EPS, $610M rev
Last earnings +0.0% on 2026-05-07
Revenue grew 22.3% YoY; but thin net margin (1.1%).
Sources: SEC EDGAR (CIK 0001759655, latest 10-Q filed 2026-05-07) · EODHD · as of 6/22/2026, 10:54:23 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Middling fundamentals and a rich price (~74% above fair value) leave little margin of safety — a wait-and-see.
Privia Health Group, Inc. shows $2.12B in FY2025 revenue (+22.3% YoY), a 1.1% net margin, and 3.1% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $966M | $1.36B | $1.66B | $1.74B | $2.12B |
| Gross profit | — | — | — | — | — |
| Operating income | -$217M | -$19.1M | $20.6M | $17.0M | $34.2M |
| Net income | -$188M | -$8.59M | $23.1M | $14.4M | $22.9M |
| Diluted EPS | -$1.83 | -$0.08 | $0.19 | $0.11 | $0.18 |
| Net margin | -19.5% | -0.6% | 1.4% | 0.8% | 1.1% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1047 tracked peers · median
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.
| 2026-05-20 | SOISTMAN FRANCIS S JR Director | Award | 8.46K | |
| 2026-05-20 | BERBERIAN LANCE Director | Award | 8.46K | |
| 2026-05-20 | COCOZZA NANCY G Director | Award | 8.46K | |
| 2026-05-20 | Kimmet Pamela O Director | Award | 8.46K | |
| 2026-05-20 | McCarthy Thomas A Director | Award | 8.46K | |
| 2026-05-20 | Morris Matthew Shawn Director | Award | 8.46K | |
| 2026-05-20 | Ryu Jaewon Director | Award | 8.46K | |
| 2026-05-20 | KING DAVID P Director | Award | 8.46K |